PMAQX | VYRIX | PMAQX / VYRIX | |
Total Expense Ratio | 0.59 | 0.77 | 77% |
Annual Report Gross Expense Ratio | 0.59 | 0.77 | 77% |
Fund Existence | 9 years | 9 years | - |
Gain YTD | 2.039 | 6.108 | 33% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 30.6B | 946M | 3,235% |
Annual Yield % from dividends | 0.19 | 0.00 | - |
Returns for 1 year | 10.62 | 9.65 | 110% |
Returns for 3 years | 50.92 | 17.15 | 297% |
Returns for 5 years | 56.82 | -1.04 | -5,473% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FDNI | 33.29 | N/A | N/A |
First Trust Dow Jones Intl Intnt ETF | |||
IGSB | 52.31 | -0.07 | -0.13% |
iShares 1-5 Year invmt Grd Corp Bd ETF | |||
GTIP | 48.86 | -0.08 | -0.17% |
Goldman Sachs Acs Infl Protd USD Bd ETF | |||
HQL | 12.85 | -0.13 | -1.00% |
abrdn Life Sciences Investors | |||
IAI | 154.06 | -2.25 | -1.44% |
iShares US Broker-Dealers&Secs Exchs ETF |